Search

Joseph R. Pokrzywa

Examiner (ID: 4325, Phone: (571)272-7410 , Office: P/3992 )

Most Active Art Unit
3992
Art Unit(s)
2625, 2622, 2722, 3992
Total Applications
418
Issued Applications
257
Pending Applications
104
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11864795 [patent_doc_number] => 20170232080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'Treatment of Migraine Headaches with Presynaptic Neurotoxin' [patent_app_type] => utility [patent_app_number] => 15/582407 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582407 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/582407
Treatment of migraine headaches with presynaptic neurotoxin Apr 27, 2017 Issued
Array ( [id] => 11992438 [patent_doc_number] => 20170296593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES' [patent_app_type] => utility [patent_app_number] => 15/581801 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581801 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/581801
CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES Apr 27, 2017 Abandoned
Array ( [id] => 11992437 [patent_doc_number] => 20170296592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES' [patent_app_type] => utility [patent_app_number] => 15/581777 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19155 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581777 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/581777
CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES Apr 27, 2017 Abandoned
Array ( [id] => 16283974 [patent_doc_number] => 20200277576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLAST CELLS [patent_app_type] => utility [patent_app_number] => 15/779244 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8769 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779244 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/779244
Method for generating induced pluripotent stem cells from fibroblast cells Apr 17, 2017 Issued
Array ( [id] => 11755347 [patent_doc_number] => 20170202214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS' [patent_app_type] => utility [patent_app_number] => 15/478733 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12527 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478733 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/478733
CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS Apr 3, 2017 Abandoned
Array ( [id] => 14233395 [patent_doc_number] => 20190128870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care [patent_app_type] => utility [patent_app_number] => 16/091434 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091434 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091434
Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care Apr 3, 2017 Abandoned
Array ( [id] => 14227529 [patent_doc_number] => 20190125937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof [patent_app_type] => utility [patent_app_number] => 16/097138 [patent_app_country] => US [patent_app_date] => 2017-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097138 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097138
Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof Apr 3, 2017 Abandoned
Array ( [id] => 11954776 [patent_doc_number] => 20170258927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'FORMULATIONS AND DOSES OF PEGYLATED URICASE' [patent_app_type] => utility [patent_app_number] => 15/456520 [patent_app_country] => US [patent_app_date] => 2017-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31073 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456520 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/456520
FORMULATIONS AND DOSES OF PEGYLATED URICASE Mar 10, 2017 Abandoned
Array ( [id] => 13871357 [patent_doc_number] => 20190032019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID [patent_app_type] => utility [patent_app_number] => 16/073352 [patent_app_country] => US [patent_app_date] => 2017-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 586 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073352 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073352
METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID Mar 8, 2017 Abandoned
Array ( [id] => 11949701 [patent_doc_number] => 20170253852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'Method of Fermenting Mycelium Composite Material' [patent_app_type] => utility [patent_app_number] => 15/450198 [patent_app_country] => US [patent_app_date] => 2017-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1645 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450198 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/450198
Method of fermenting mycelium composite material Mar 5, 2017 Issued
Array ( [id] => 16785264 [patent_doc_number] => 10987669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Apparatus and method for detection of tumour cells and circulating tumour cells [patent_app_type] => utility [patent_app_number] => 16/081720 [patent_app_country] => US [patent_app_date] => 2017-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18109 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081720 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/081720
Apparatus and method for detection of tumour cells and circulating tumour cells Mar 2, 2017 Issued
Array ( [id] => 13982417 [patent_doc_number] => 20190060366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/080264 [patent_app_country] => US [patent_app_date] => 2017-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080264 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/080264
HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS Feb 26, 2017 Abandoned
Array ( [id] => 13827089 [patent_doc_number] => 20190017029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Generation of Expandable Cardiovascular Progenitor Cells [patent_app_type] => utility [patent_app_number] => 16/076824 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076824
Generation of Expandable Cardiovascular Progenitor Cells Feb 23, 2017 Abandoned
Array ( [id] => 11668349 [patent_doc_number] => 20170157069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS' [patent_app_type] => utility [patent_app_number] => 15/440738 [patent_app_country] => US [patent_app_date] => 2017-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7982 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440738 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/440738
COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS Feb 22, 2017 Abandoned
Array ( [id] => 12117289 [patent_doc_number] => 20180000875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS' [patent_app_type] => utility [patent_app_number] => 15/434376 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10244 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434376 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/434376
PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS Feb 15, 2017 Abandoned
Array ( [id] => 14454613 [patent_doc_number] => 10323259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Formulation and process for biohydrogen production [patent_app_type] => utility [patent_app_number] => 15/426815 [patent_app_country] => US [patent_app_date] => 2017-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6544 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426815 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/426815
Formulation and process for biohydrogen production Feb 6, 2017 Issued
Array ( [id] => 14291999 [patent_doc_number] => 10286108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Irreversible electroporation to create tissue scaffolds [patent_app_type] => utility [patent_app_number] => 15/423986 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9826 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423986 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/423986
Irreversible electroporation to create tissue scaffolds Feb 2, 2017 Issued
Array ( [id] => 14243991 [patent_doc_number] => 10272178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Methods for blood-brain barrier disruption using electrical energy [patent_app_type] => utility [patent_app_number] => 15/424335 [patent_app_country] => US [patent_app_date] => 2017-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11995 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424335 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/424335
Methods for blood-brain barrier disruption using electrical energy Feb 2, 2017 Issued
Array ( [id] => 12707668 [patent_doc_number] => 20180127722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF [patent_app_type] => utility [patent_app_number] => 15/416502 [patent_app_country] => US [patent_app_date] => 2017-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416502 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/416502
COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF Jan 25, 2017 Abandoned
Array ( [id] => 13824135 [patent_doc_number] => 20190015552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => Vascular Extracellular Matrix Hydrogel [patent_app_type] => utility [patent_app_number] => 16/070044 [patent_app_country] => US [patent_app_date] => 2017-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070044 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/070044
Vascular extracellular matrix hydrogel Jan 12, 2017 Issued
Menu